Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies.
about
Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysisExpanding the scope of nursing research in low resource and middle resource countries, regions, and states focused on cervical cancer prevention, early detection, and controlExpression of Estrogen and Progesterone Receptor in Tumor Stroma Predicts Favorable Prognosis of Cervical Squamous Cell Carcinoma.South African National Cancer Registry: Effect of withheld data from private health systems on cancer incidence estimates.Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological stuInequalities in the incidence of cervical cancer in South East England 2001-2005: an investigation of population risk factors.Immuno-related polymorphisms and cervical cancer risk: The IARC multicentric case-control studyAntiestrogen use reduces risk of cervical neoplasia in breast cancer patients: a population-based study.Increasing rates of cervical cancer in young women in England: an analysis of national data 1982-2006.Estrogen and ERalpha: culprits in cervical cancer?50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence.Hormonal contraception and risk of cancer.Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinantsThe role of co-factors in the progression from human papillomavirus infection to cervical cancerHuman papillomavirus testing in the prevention of cervical cancerHuman papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational studyOncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer.A study on cervical cancer screening amongst nurses in Lagos University Teaching Hospital, Lagos, NigeriaWhat women in the United States Virgin Islands still want and need to know about HPV, cervical cancer, and condom use.Past and future of prophylactic ablation of the cervical squamocolumnar junctionHigh-Risk Human Papillomavirus (HPV) Infection and Cervical Cancer Prevention in Britain: Evidence of Differential Uptake of Interventions from a Probability Survey.Comparison of Age- Standard Incidence Rate Trends of Gynecologic and Breast Cancer in Iran and Other Countries.The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population.Age-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopyThe Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC CohortA Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study.Comparison of the efficacy among multiple chemotherapeutic interventions combined with radiation therapy for patients with cervix cancer after surgery: A network meta-analysis.Bereavement Is Associated with an Increased Risk of HPV Infection and Cervical Cancer: An Epidemiological Study in Sweden.Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-upCervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens.Nativity differences in behaviors associated with high-risk HPV infection among Hispanic women in Houston, Texas, USA.Awareness of cervical cancer risk factors and symptoms: cross-sectional community survey in post-conflict northern Uganda.Age of diagnosis of squamous cell cervical carcinoma and early sexual experience.Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.Differences in the risk of cervical cancer and human papillomavirus infection by education level.Time since first sexual intercourse and the risk of cervical cancer.Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.The burden of cervical cancer in China: synthesis of the evidence.Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact.Human papillomavirus in adolescents: lessons learned from decades of evaluation.
P2860
Q28281796-4A16D339-2276-4ECE-97CA-78CEFA30ABAFQ28391812-3C917064-8315-4876-8570-B5C811492D1DQ30491596-4897F247-CE54-4D69-AB87-F000B50A210EQ30985177-3BF423BC-773F-4A8E-BA08-3E441C894D60Q31080770-CB20BFA2-3026-44A1-A2DA-290A3D25C3EAQ33411029-26FDB171-F423-40E6-81A3-ADC2CAB6F954Q33688320-BA49A267-5300-4791-859C-F7A60D036DEDQ33710124-3F0B4570-5FE5-48D1-87FA-F8F0B9B405ACQ33926729-62FD6A80-1730-4252-9BBB-70CB48A0AE7CQ34037344-7DDA6BF4-7DEF-44CF-9952-B70AA044D2C0Q34113534-236CC06D-038B-4871-9E19-1D1752908F79Q34120493-523A88E5-A81D-490A-80B1-74ED9E3EBE8BQ34187446-BD3035CA-73EE-4DB4-952A-6CF37697058EQ34311313-E5586C9E-C3D7-4EB0-AB5A-4463CCBBF150Q34616083-DBEF4521-F7F5-41FB-A486-D1835384B649Q34987731-ECAB9395-6DD1-43E8-8A49-BC81AB1C42DBQ35054754-92699785-CB0C-4873-9633-BD85271A4CF4Q35179612-05CC7E5D-B391-418E-96F7-281ED019C635Q35207460-233C2DCA-E65F-4D42-A23F-23A7A4505D25Q35605616-ACE46055-5361-440D-9E04-B5FAAC7E258CQ35619059-DC489B20-C428-48DE-B439-0EC52320C216Q35639116-1FBB24F6-029D-463B-960E-E603126BA602Q35677525-8BFA82C9-8DD9-4A3D-9483-D7710AAECCD1Q35699092-EFD4FC18-40D9-4C7E-9653-7F00981908F2Q35903393-30215A5E-521F-4282-BC6D-BDA2AA52FDE1Q36194694-5C95EFCC-D399-458D-BA70-11075D694744Q36363546-1248CE19-8164-4CCE-9D64-EFF71A3F03C3Q36535190-E4360A93-5A0E-4DB9-A271-DE985036F18AQ36557818-75BC7A34-6C1E-4FB9-98A4-0A018B2C7F52Q36813303-CDA957E0-AA27-426F-B422-C3CCE9CACAF0Q36909158-723F0927-C7DF-434E-B311-00EA8A6BA533Q37118779-4C19BAF0-D563-4C1F-939A-05B4A8ADED20Q37154929-700561D6-D820-4CD7-A139-9D0881C211A5Q37225731-8DC780BF-9CFA-47E0-AADC-31B1A21ADA4AQ37330752-64B826AF-20F8-4676-88FF-2907846A4211Q37695585-9588755A-EA66-41C9-8015-490E92B06B9DQ37848402-5F26972E-83A1-425A-B46A-A41A0101B9E2Q37851067-72383EC1-6AB3-401B-A270-4FE8EE8AE22AQ37912228-8C41FA3B-D6E7-4CA7-B5FE-FBBDC67C696FQ37924908-6D0F5A16-4253-44DC-A8BB-4007446C6B2C
P2860
Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Cervical carcinoma and reprodu ...... om 25 epidemiological studies.
@ast
Cervical carcinoma and reprodu ...... om 25 epidemiological studies.
@en
type
label
Cervical carcinoma and reprodu ...... om 25 epidemiological studies.
@ast
Cervical carcinoma and reprodu ...... om 25 epidemiological studies.
@en
prefLabel
Cervical carcinoma and reprodu ...... om 25 epidemiological studies.
@ast
Cervical carcinoma and reprodu ...... om 25 epidemiological studies.
@en
P2860
P356
P1476
Cervical carcinoma and reprodu ...... om 25 epidemiological studies.
@en
P2093
International Collaboration of Epidemiological Studies of Cervical Cancer
P2860
P304
P356
10.1002/IJC.21953
P577
2006-09-01T00:00:00Z